✦ LIBER ✦

Growth rates of metastatic brain tumors in nonsmall cell lung cancer

✍ Scribed by Heon Yoo; Byung-Ho Nam; Hee-Seok Yang; Sang Hoon Shin; Jin Soo Lee; Seung Hoon Lee

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 210 KB
Volume: 113
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.23676

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

UHRF1-mediated tumor suppressor gene ina

UHRF1-mediated tumor suppressor gene inactivation in nonsmall cell lung cancer

✍ Alexandros Daskalos; Urszula Oleksiewicz; Anastasia Filia; George Nikolaidis; Ge 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 508 KB

Prognostic significance of angiogenesis

Prognostic significance of angiogenesis and angiogenic growth factors in nonsmall cell lung cancer

✍ Ravi Salgia 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB

Inactivation of LLC1 gene in nonsmall ce

Inactivation of LLC1 gene in nonsmall cell lung cancer

✍ Kyeong-Man Hong; Sei-Hoon Yang; Sinchita Roy Chowdhuri; Audrey Player; Megan Ham 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 448 KB 👁 2 views

## Abstract Serial analysis of gene expression studies led us to identify a previously unknown gene, c20orf85, that is present in the normal lung epithelium but absent or downregulated in most primary nonsmall cell lung cancers and lung cancer cell lines. We named this gene __LLC1__ for __L__ow in

Number of metastatic sites is a strong p

Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases

✍ Yun Oh; Sarah Taylor; Benjamin Nebiyou Bekele; J. Matthew Debnam; Pamela K. Alle 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 383 KB 👁 2 views

Implications of key trials in advanced n

Implications of key trials in advanced nonsmall cell lung cancer

✍ Philip D. Bonomi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 1 views

## Abstract Many different targeted therapies with varying mechanisms of action have been added to standard first‐line chemotherapy doublets in an effort to improve survival of patients with advanced nonsmall cell lung cancer (NSCLC). Only 2 targeted therapies—bevacizumab and cetuximab—have been as

Two radiation regimens and prognostic fa

Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients

✍ Dirk Rades; Steven E. Schild; Radka Lohynska; Theo Veninga; Lukas JA Stalpers; J 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

## Abstract ## BACKGROUND. Nonsmall cell lung cancer (NSCLC) patients with brain metastases usually receive whole‐brain radiotherapy (WBRT). Most of these patients survive for only a few months. A short course of WBRT would be preferable to longer regimens if it could provide similar survival. Thi